Vol. 40 | No. 1 | January-June 2012Back

Open Access

Tetralogy of Fallot: A Philippine Heart Center Review

More Info

Raul D. Jara, MD, Mikaela Nikkola A. Jara, MD 

Philippine Heart Center, Quezon City 

 

FUNDING: Funding has been done by personal accounts of the authors. Dr. Raul Jara is the Chairperson of the Department of Education, Training, and Research, PHC. There are no potential conflicts of interest with regards to this study.

  1. Fox D, Devendra GP, Hart SA, Krasuski RA. When Blue Babies Grow Up: What you Need to Know about Tetralogy of Fallot. Cleveland Clinic Journal of Medicine, 2010; 77 (1): 821-828. 
  2. Lopez W, Balderas J. et.al. (2010). Philippine Heart Center Department of Pediatric Cardiology Census (2000-2005). Unpublished paper. 
  3. Sommer RJ, Hijazi ZM, Rhodes JF. Pathophysiology of Congenital Heart Disease in the Adult. Circulation 2008; 117: 1340-1350. 
  4. Gamponia RT. Personal Interview with Mikaela Nikkola Jara. Quezon City. 18 January 2012. 
  5. Claudio MTE. (2004). Preoperative echocardiographic predictors of outcome of pediatric patients undergoing total tetralogy of Fallot correction. CRF.R.006.04. Unpublished paper. 
  6. Perfecto SM, Casas ML, Estevanez CA. (2008). Late complications following tetralogy of Fallot repair: A 5-10 year review. PHC.R.060.08. Unpublished paper. 
  7. Delfin D P, Jacoba KG, Divinagracia RA. Clinical outcome of adult tetralogy of Fallot after total surgical correction. Phil J Cardiol, 1991; 2: 675-680. 
  8. Bote-Nunez JR, Cantre T, Casas MLS. (2001). Long-term results after total repair of Tetralogy of Fallot. PHC.R.053.01. Unpublished paper. 
  9. Griffin BP, Topol EJ. Manual of Cardiovascular Medicine 3rd edition. Philadelphia: Wolsters Kluwer and Lipincott Williams &Wilkins, 2009. 
  10. Villanueva NJ. (1988). Results of Repair of Tetralogy of Fallot at the Philippine Heart Center 1984-1987. PHC.R.039.88. Unpublished paper. 
  11. Claudio MTE, Casas MLS. (2002). Predictors of early morbidity and mortality among pediatric patients who underwent total tetralogy of Fallot correction. PHC.R.049.02. Unpublished paper. 
  12. Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 9th ed. Philadelphia: Elsevier, 2012. 
  13. Lazaro MER, Azcueta MBA, Balderas JJ, Casas MLSR, Lagamayo MJ. Comparison of outcome of tetralogy of Fallot after surgical correction and right ventricular outflow tract reconstruction using Gore-Text (PTFE) monocusp versus non valved transannular technique. Phil J Cardiol 2005:33:193- 195. 
  14. Turrentine MW. (February 13, 2008). PTFE Monocusp Valve for RVOT Reconstruction. In The Cardiothoracic Network Society. Retrieved December 22, 2011, from http:// www.ctsnet.org/sections/clinicalresources/congenital/ expert_tech-1.html. 
  15. Daen CP, Tan A, Gamponia RT, Casas MLS, Gamponia AS, Collado EC, Cantre TC, Lopez WL. Late result of right ventricular outflow tract reconstruction with pericardial monocusp pulmonary valve among children with tetralogy of Fallot. Phil Heart Center J 1996:3:14-18. 
  16. Del Campo JFM, Latosa E, Casas MLS, Cantre TC. (1998). Arrhytmias after Total Correction of Tetralogy of Fallot: Atriotomy vs. Ventriculotomy. PHC.R.151.98. Unpublished paper. 
  17. Bensurto ES, Azcueta BA, Latosa ED, Casas MLS, Cantre TC. Preoperative left ventricular indices as predictor of tetralogy of Fallot corrective surgery outcome. Philippine Journal of Pediatrics, 2000 Apr-Jun 49(2):117-121. 
  18. Yap MC, Casas LS, Balderas JB, Lagamayo MJ. (2008) The association of post-operative cognitive outcome, perioperative factors and the timing of surgery in tetralogy of Fallot patients. PHC.R.008.08. Unpublished paper. 
  19. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000; 356:975– 981. 
  20. Del Campo JFM. (2000). The efficacy of esmolol for the treatment of hypoxic spells in tetralogy of Fallot. PHC.R.022.99. Unpublished paper. 

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.